Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 100

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 100
---
. Evanko, Noelle K. Eder, Nicole S. Jones, and Eric P. Palmer

2022: Brian C. Evanko, Noelle K. Eder, Nicole S. Jones, and Eric P. Palmer

2021: Brian C. Evanko, Nicole S. Jones, Eric P. Palmer. Timothy Wentworth, and Matthew Manders

2020: Nicole S. Jones, Eric P. Palmer. Timothy Wentworth, and Matthew Manders

(3) Peer Group reflects published data for the S&P 500 Health Care Index.

(4) Reflects “Shareholders’ Net Income” per SEC requirements.

(5) For purposes of this section, we have identified adjusted income from operations, per shareas our Company-Selected Measure, the calculation of which is described in our Annual Report on Form 10-K for the year ended December 31, 2024. Additional information regarding our use of non-GAAP measures and reconciliations to the most directly comparable GAAP measure can be found on Annex A.

Compensation Actually Paid Versus Company TSR and Peer Group TSR

Over the five-year period (2020–2024), the Company’s cumulative TSR grew 44.7%. Over the same period, cumulative TSR for the S&P 500 Health Care Index grew 46.9%. Over this same period, Compensation Actually Paid for the PEO and the average across the non-PEO NEOs grew by 20.6% and 13.0%, respectively. Over the five-year period, Mr. Cordani’s and the other NEOs’ Compensation Actually Paid amounts were generally aligned with the Company’s TSR as compared to the S&P 500 Health Care Index. This is due primarily to the Company’s use of equity incentives, which are tied directly to the Company’s stock price and financial performance on an absolute basis and relative to its peers. In addition, 50% of an SPS award’s payout is aligned to relative TSR performance as compared to a custom peer group as described in the Compensation Discussion & Analysis within the section titled “Executive Compensation Policies and Practices.”

The graph below compares The Cigna Group cumulative TSR to the S&P 500 Index and the S&P 500 Health Care Index for the five-year period ended December 31, 2024, which we believe provides a more fulsome understanding of the Company’s market performance given the longer time horizon. The stock performance shown in the graph is not intended to forecast or be indicative of future